339 related articles for article (PubMed ID: 12180718)
1. Hyperhomocysteinemia in rheumatoid arthritis: influence of methotrexate treatment and folic acid supplementation.
Jensen OK; Rasmussen C; Mollerup F; Christensen PB; Hansen H; Ekelund S; Thulstrup AM
J Rheumatol; 2002 Aug; 29(8):1615-8. PubMed ID: 12180718
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: implications for cardiovascular disease prevention.
Morgan SL; Baggott JE; Lee JY; Alarcón GS
J Rheumatol; 1998 Mar; 25(3):441-6. PubMed ID: 9517760
[TBL] [Abstract][Full Text] [Related]
3. Folate supplementation and methotrexate treatment in rheumatoid arthritis: a review.
Whittle SL; Hughes RA
Rheumatology (Oxford); 2004 Mar; 43(3):267-71. PubMed ID: 14963199
[TBL] [Abstract][Full Text] [Related]
4. Folate, homocysteine, and cobalamin status in patients with rheumatoid arthritis treated with methotrexate, and the effect of low dose folic acid supplement.
Hornung N; Ellingsen T; Stengaard-Pedersen K; Poulsen JH
J Rheumatol; 2004 Dec; 31(12):2374-81. PubMed ID: 15570637
[TBL] [Abstract][Full Text] [Related]
5. Intermittent rises in plasma homocysteine in patients with rheumatoid arthritis treated with higher dose methotrexate.
Hoekstra M; Haagsma CJ; Doelman CJ; van de Laar MA
Ann Rheum Dis; 2005 Jan; 64(1):141-3. PubMed ID: 15608313
[TBL] [Abstract][Full Text] [Related]
6. Reduction of the efficacy of methotrexate by the use of folic acid: post hoc analysis from two randomized controlled studies.
Khanna D; Park GS; Paulus HE; Simpson KM; Elashoff D; Cohen SB; Emery P; Dorrier C; Furst DE
Arthritis Rheum; 2005 Oct; 52(10):3030-8. PubMed ID: 16200612
[TBL] [Abstract][Full Text] [Related]
7. Reduced folate carrier-1 80G>A polymorphism affects methotrexate treatment outcome in rheumatoid arthritis.
Drozdzik M; Rudas T; Pawlik A; Gornik W; Kurzawski M; Herczynska M
Pharmacogenomics J; 2007 Dec; 7(6):404-7. PubMed ID: 17325736
[TBL] [Abstract][Full Text] [Related]
8. 2756GG genotype of methionine synthase reductase gene is more prevalent in rheumatoid arthritis patients treated with methotrexate and is associated with methotrexate-induced nodulosis.
Berkun Y; Abou Atta I; Rubinow A; Orbach H; Levartovsky D; Aamar S; Arbel O; Dresner-Pollak R; Friedman G; Ben-Yehuda A
J Rheumatol; 2007 Aug; 34(8):1664-9. PubMed ID: 17611986
[TBL] [Abstract][Full Text] [Related]
9. The effect of folic acid and folinic acid supplements on purine metabolism in methotrexate-treated rheumatoid arthritis.
Morgan SL; Oster RA; Lee JY; Alarcón GS; Baggott JE
Arthritis Rheum; 2004 Oct; 50(10):3104-11. PubMed ID: 15476202
[TBL] [Abstract][Full Text] [Related]
10. Common polymorphisms in the folate pathway predict efficacy of combination regimens containing methotrexate and sulfasalazine in early rheumatoid arthritis.
James HM; Gillis D; Hissaria P; Lester S; Somogyi AA; Cleland LG; Proudman SM
J Rheumatol; 2008 Apr; 35(4):562-71. PubMed ID: 18322994
[TBL] [Abstract][Full Text] [Related]
11. Economic evaluation of folate supplementation during methotrexate treatment in rheumatoid arthritis.
Hartman M; van Ede A; Severens JL; Laan RF; van de Putte L; van der Wilt GJ
J Rheumatol; 2004 May; 31(5):902-8. PubMed ID: 15124248
[TBL] [Abstract][Full Text] [Related]
12. Evidence of the symptomatic and structural efficacy of methotrexate in daily practice as the first disease-modifying drug in rheumatoid arthritis despite its suboptimal use: results from the ESPOIR early synovitis cohort.
Gaujoux-Viala C; Paternotte S; Combe B; Dougados M
Rheumatology (Oxford); 2012 Sep; 51(9):1648-54. PubMed ID: 22661552
[TBL] [Abstract][Full Text] [Related]
13. Methotrexate polyglutamate concentrations are not associated with disease control in rheumatoid arthritis patients receiving long-term methotrexate therapy.
Stamp LK; O'Donnell JL; Chapman PT; Zhang M; James J; Frampton C; Barclay ML
Arthritis Rheum; 2010 Feb; 62(2):359-68. PubMed ID: 20112376
[TBL] [Abstract][Full Text] [Related]
14. Longterm observational study of methotrexate use in a Dutch cohort of 1022 patients with rheumatoid arthritis.
Hoekstra M; van de Laar MA; Bernelot Moens HJ; Kruijsen MW; Haagsma CJ
J Rheumatol; 2003 Nov; 30(11):2325-9. PubMed ID: 14677172
[TBL] [Abstract][Full Text] [Related]
15. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.
Shea B; Swinden MV; Tanjong Ghogomu E; Ortiz Z; Katchamart W; Rader T; Bombardier C; Wells GA; Tugwell P
Cochrane Database Syst Rev; 2013 May; 2013(5):CD000951. PubMed ID: 23728635
[TBL] [Abstract][Full Text] [Related]
16. Controlled trial of methotrexate versus CH-1504 in the treatment of rheumatoid arthritis.
Castaneda O; Nair MG
J Rheumatol; 2006 May; 33(5):862-4. PubMed ID: 16652417
[TBL] [Abstract][Full Text] [Related]
17. The safety and efficacy of adding etanercept to methotrexate or methotrexate to etanercept in moderately active rheumatoid arthritis patients previously treated with monotherapy.
van der Heijde D; Burmester G; Melo-Gomes J; Codreanu C; Mola EM; Pedersen R; Freundlich B; Chang DJ;
Ann Rheum Dis; 2008 Feb; 67(2):182-8. PubMed ID: 17728331
[TBL] [Abstract][Full Text] [Related]
18. Hyperhomocysteinemia in children treated with antiepileptic drugs is normalized by folic acid supplementation.
Huemer M; Ausserer B; Graninger G; Hubmann M; Huemer C; Schlachter K; Tscharre A; Ulmer H; Simma B
Epilepsia; 2005 Oct; 46(10):1677-83. PubMed ID: 16190942
[TBL] [Abstract][Full Text] [Related]
19. Prospectively measured red cell folate levels in methotrexate treated patients with rheumatoid arthritis: relation to withdrawal and side effects.
Andersen LS; Hansen EL; Knudsen JB; Wester JU; Hansen GV; Hansen TM
J Rheumatol; 1997 May; 24(5):830-7. PubMed ID: 9150068
[TBL] [Abstract][Full Text] [Related]
20. Determinants of red blood cell methotrexate polyglutamate concentrations in rheumatoid arthritis patients receiving long-term methotrexate treatment.
Stamp LK; O'Donnell JL; Chapman PT; Zhang M; Frampton C; James J; Barclay ML
Arthritis Rheum; 2009 Aug; 60(8):2248-56. PubMed ID: 19644853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
